TCI Wealth Advisors’s Kura Oncology KURA Stock Holding History

TCI Wealth Advisors’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-318	Closed	-$3.95K	–	2585
2022 Q4	$3.95K	Hold	318	–	–	﹤0.01%	1687
2022 Q3	$4K	Hold	318	–	–	﹤0.01%	1624
2022 Q2	$6K	Hold	318	–	–	﹤0.01%	1367
2022 Q1	$5K	Buy	+318	New	+$4.59K	﹤0.01%	1565
2021 Q4	–	Sell	-160	Closed	-$3K	–	2425
2021 Q3	$3K	Buy	+160	New	+$3.02K	﹤0.01%	1955
2021 Q2	–	Sell	-64	Closed	-$2K	–	2388
2021 Q1	$2K	Buy	+64	New	+$2.02K	﹤0.01%	1790

Other funds holding KURA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCI Wealth Advisors's KURA Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Kura Oncology (KURA) in Q1 2023, closing a stake of 318 shares — an estimated $3.95K sold.

TCI Wealth Advisors first reported a position in KURA in Q1 2021 and held it in 6 quarters. The position peaked at $6K in Q2 2022. 141 funds tracked by Wall St. Rank hold KURA as of Q1 2023.

TCI Wealth Advisors reported no remaining Kura Oncology position as of Q1 2023 after selling out during the quarter.
TCI Wealth Advisors sold 318 Kura Oncology shares in Q1 2023, an estimated $3.95K.
TCI Wealth Advisors first reported a position in Kura Oncology in Q1 2021 and held it in 6 quarters.
TCI Wealth Advisors's Kura Oncology position peaked at $6K in Q2 2022.
141 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.